Guest Christa Smolke, Co-founder and CEO of Antheia, discusses turning yeast cells into tiny factories for drug production, potentially solving drug shortage issues. The podcast explores the challenges of engineering yeast to produce drugs, the use of yeast in disrupting traditional farming methods for drug ingredients, and the benefits of therapy and bioengineering insights.